Emyria has today announced the appointment of a new high profile Independent Non-Executive Chairman today, Mr. Greg Hutchinson, to bolster its innovative mental health R&D program.
Greg’s tenure as CEO of Sonic HealthPlus and Deputy CEO of Sonic Clinical Services underscores significant expertise in sustaining and scaling frontline health services and research programs, which will be invaluable for Emyria as the Company embraces an important chapter of commercial growth.
Outgoing Chairman, Dr. Stewart Washer, will now resume an advisory role.
Emyria CEO and MD, Dr. Michael Winlo, said:
“Stewart has been instrumental in our journey so far, laying the foundations of a company committed to personalised therapy and data acquisition to guide the development of innovative treatments to address unmet clinical needs.
“We are excited to welcome Greg, whose exceptional track record in founding and scaling clinical operations and healthcare management will be pivotal in our next growth phase, particularly in expanding our MDMA-assisted therapy program.”